Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
Development of Antibiotic Resistance over Three Decades in the Cystic Fibrosis Pathogen, Pseudomonas aeruginosa
EF 2015-16
Résumé
Cystic fibrosis (CF) is the most common fatal genetic disease in Canada with mortality driven by bacterial infection of the lungs. Chronic lung infection, particularly by the preeminent CF pathogen Pseudomonas aeruginosa, leads to worse outcomes for CF patients. Of particular concern is that treatment of the bacterium is complicated by its ability to quickly develop resistance to antibiotics, resulting in difficulties effectively treating the infection. To address this challenge, computational tools have been developed to utilize genetic data and predict antibiotic resistance profiles; however, these tools may fail to properly characterize P. aeruginiosa resistance, due to the bacterium's diverse resistance mechanisms. Our lab has access to a collection of P. aeruginosa samples that spans three decades. I will explore this sample collection to acquire 200 total P. aeruginosa isolates from 100 patients for sequencing of their genome. I will examine and compare the efficacy of several computational tools in analyzing the genetic content of these isolates. I will also explore how these transmissible isolates travelled through the clinic to see whether any opportunities for infection control improvement exist. Finally, I will conduct antibiotic resistance profiling on the isolates in a laboratory and compare these results to those predicted by computational tools. This project will provide not only better understanding of the P. aeruginosa bacteria and how it develops antibiotic resistance, but also direction for the improvement of available computational tools. This will then aid in bridging the divide between basic research and clinical practice and may allow for personalized antibiotic therapies in the future.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
349996
Name
Syed Saad
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Development of Antibiotic Resistance over Three Decades in the Cystic Fibrosis Pathogen, Pseudomonas aeruginosa
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antibiotic Resistance; Bioinformatics; Chronic Lung Disease; Comparative Genomics; Cystic Fibrosis; Evolutionary Genomics; Infectious Disease; Pseudomonas Aeruginosa; Whole Genome Sequencing
Abstract
Cystic fibrosis (CF) is the most common fatal genetic disease in Canada with mortality driven by bacterial infection of the lungs. Chronic lung infection, particularly by the preeminent CF pathogen Pseudomonas aeruginosa, leads to worse outcomes for CF patients. Of particular concern is that treatment of the bacterium is complicated by its ability to quickly develop resistance to antibiotics, resulting in difficulties effectively treating the infection. To address this challenge, computational tools have been developed to utilize genetic data and predict antibiotic resistance profiles; however, these tools may fail to properly characterize P. aeruginiosa resistance, due to the bacterium's diverse resistance mechanisms. Our lab has access to a collection of P. aeruginosa samples that spans three decades. I will explore this sample collection to acquire 200 total P. aeruginosa isolates from 100 patients for sequencing of their genome. I will examine and compare the efficacy of several computational tools in analyzing the genetic content of these isolates. I will also explore how these transmissible isolates travelled through the clinic to see whether any opportunities for infection control improvement exist. Finally, I will conduct antibiotic resistance profiling on the isolates in a laboratory and compare these results to those predicted by computational tools. This project will provide not only better understanding of the P. aeruginosa bacteria and how it develops antibiotic resistance, but also direction for the improvement of available computational tools. This will then aid in bridging the divide between basic research and clinical practice and may allow for personalized antibiotic therapies in the future.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Syed, Saad
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~